ArticleJournal of pharmaceutical health care and sciences2025

Clinical efficacy of casirivimab and imdevimab in preventing COVID-19 in the Omicron BA.5 subvariant epidemic: a retrospective study.

Mariko Ohtani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.